Solara Active Pharma Sciences Limited (NSE:SOLARA)
India · Delayed Price · Currency is INR 449.55
-9.50 (-2.07%)
At close: Mar 9, 2026
NSE:SOLARA Market Cap
NSE:SOLARA has a market cap or net worth of 21.66 billion as of March 9, 2026. Its market cap has decreased by -9.86% in one year.
Market Cap
21.66B
Enterprise Value
28.10B
Revenue
12.55B
Ranking
n/a
PE Ratio
n/a
Stock Price
449.55
Market Cap Chart
Since June 27, 2018, NSE:SOLARA's market cap has increased from 6.21B to 21.66B, an increase of 248.62%. That is a compound annual growth rate of 17.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 22.11B | -18.75% |
| Dec 31, 2025 | 27.21B | -16.57% |
| Dec 31, 2024 | 32.62B | 150.91% |
| Dec 29, 2023 | 13.00B | -16.05% |
| Dec 30, 2022 | 15.49B | -57.73% |
| Dec 31, 2021 | 36.63B | -14.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 27, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aarti Pharmalabs | 63.47B |
| Sun Pharma Advanced Research Company | 40.23B |
| Innova Captab | 38.91B |
| RPG Life Sciences | 30.97B |
| Orchid Pharma | 25.79B |
| Indoco Remedies | 18.31B |
| Windlas Biotech | 15.58B |
| Ind-Swift Laboratories | 11.87B |